Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) stock closed at 0.081 per share at the end of the most recent trading day (a 2.21% change compared to the prior day closing price) with a volume of 210.85K shares and market capitalization of 3.61M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 32 people. Aridis Pharmaceuticals Inc. CEO is Vu Truong.

The one-year performance of Aridis Pharmaceuticals Inc. stock is -91.29%, while year-to-date (YTD) performance is -93.14%. ARDS stock has a five-year performance of -99.24%. Its 52-week range is between 0.05 and 1.7458, which gives ARDS stock a 52-week price range ratio of 1.83%

Aridis Pharmaceuticals Inc. currently has a PE ratio of -0.80, a price-to-book (PB) ratio of 15.71, a price-to-sale (PS) ratio of 166.17, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -171.67%, a ROC of -770.63% and a ROE of 164.06%. The company’s profit margin is -%, its EBITDA margin is -3 058.50%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Aridis Pharmaceuticals Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Aridis Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Aridis Pharmaceuticals Inc. is Strong Buy (1), with a target price of $10.5, which is +12 863.00% compared to the current price. The earnings rating for Aridis Pharmaceuticals Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aridis Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aridis Pharmaceuticals Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.95, ATR14 : 0.02, CCI20 : 13.64, Chaikin Money Flow : -0.55, MACD : 0.00, Money Flow Index : 77.94, ROC : 18.25, RSI : 51.21, STOCH (14,3) : 58.82, STOCH RSI : 0.57, UO : 29.05, Williams %R : -41.18), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aridis Pharmaceuticals Inc. in the last 12-months were: Eric Patzer (Sold 0 shares of value $0 ), Jafri Hasan (Sold 0 shares of value $0 ), Kurland Fred (Sold 0 shares of value $0 ), Vu Truong (Sold 0 shares of value $0 ), Windham-Bannister Susan (Sold 0 shares of value $0 )